SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: Robohogs who wrote (1699)7/3/2003 9:52:22 AM
From: Icebrg  Read Replies (2) | Respond to of 3044
 
>>That must mean the Swiss spend about the same as the U.S. on a per person basis given differences in incomes, except that 10-30% of Americans are not fully treated>>

Does it? I am getting confused.

In Switzerland everyone is treated and the cost is 10,7 % per person.

In the US only between 70 and 90 percent of the population is treated, but you still spend 13,0 % of your GDP on healthcare. If everyone would be covered, the proportion of your resources used for this purpose would be even higher.

A figure I have of the situation per July 2001, gives a GDP per capita of USD 36.200 for the US but only USD 28.600 for Switzerland. Sweden is to be found at 22.200 USD. The average treated American will cost abt 4.700 USD per year, while the cost for the average Swiss is only 3.060. And here in Sweden we can only afford to spend 1.750 USD per year and person on healthcare. Those relations will change somewhat with the exchange rates.

Now, there are of course no guarantees that the costs are defined and calculated in the same way. Most probably they are not. But there will still be substantial differences.

Erik